Gedatolisib (Compound)

Synonyms:Gedatolisib, 1197160-78-3, PKI-587, PF-05212384, PKI 587, 1-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea, PKI587, PF-05212384 (PKI-587), PF 05212384, Gedatolisib(PKI-587), CHEMBL592445, 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, 96265TNH2R, N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea, Gedatolisib (PF-05212384, PKI-587), PKI-587; PF-05212384, Urea, N-(4-((4-(dimethylamino)-1-piperidinyl)carbonyl)phenyl)-N'-(4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl)-, 1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea, Gedatolisib [USAN:INN], UNII-96265TNH2R, 1-(4-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, Urea, N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-, PK 587, PK 1587, GEDATOLISIB [INN], Gedatolisib (USAN/INN), GEDATOLISIB [USAN], Gedatolisib (PKI-587), SCHEMBL32393, GEDATOLISIB [WHO-DD], GTPL7940, DTXSID40152557, EX-A028, HMS3748M11, BCP01986, BDBM50308135, MFCD16875679, NSC758256, NSC801014, s2628, AKOS005766013, CCG-264662, CS-0449, DB11896, FE-0013, NSC-758256, NSC-801014, SB16571, NCGC00370777-01, NCGC00370777-04, AC-31519, HY-10681, FT-0700110, PKI-587,PF-05212384, A25474, D10635, J-004182, J-523339, Q27077788, PKI-587|1197160-78-3|PKI587|PKI 587, N-(4-((4-(DIMETHYLAMINO)-1-PIPERIDINYL)CARBONYL)PHENYL)-N'-(4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL)UREA, N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]urea, VL1

Id:44516953

Description:nan